I-PSS score (6.8 vs 6.9, p ¼0.69), nor mean FSFI score (22.9 vs 23.2, p¼ 0.68) compared to lower intensity cyclists. High intensity cyclists were more likely to develop perineal numbness, OR 1.6 (95% CI 1.3-2), and saddle sores, OR 2.2 (95% CI 1.8-2.8). Bike seat type had no significant effect in any of the above mentioned results.
INTRODUCTION AND OBJECTIVES: There is wide clinical overlap between PVD and IC/BPS as both conditions may include dyspareunia, chronic pelvic pain, and lower urinary tract symptoms. Unlike with IC/BPS evaluation, PVD patients are distinguished by having confined vestibular pain and positive cotton swab (Q-tip) testing, often with erythema and tenderness at 1:00 and 11:00 peri-urethral Skene's vestibular glands. Successful treatment of PVD has been anecdotally observed to resolve IC/BPS patient bladder symptoms. In addition, treatment of PVD often leads to resolution of gland pathology. The goal of this study was to advance our knowledge concerning the association of successful treatment for PVD and subsequent bladder symptom improvement.
METHODS: An IRB-approved anonymous multi-question internet-based survey was sent to 233 consecutive women who were diagnosed and successfully treated for PVD by two sexual medicine physicians.
RESULTS: 73 (31%) women responded: 55% were 21 -35 years old. Most common symptoms were dyspareunia (93%), feelings of burning, raw or cutting in the pelvis (75%), pain with tampons (52%), urinary frequency (38%), urgency (30%), bladder pain (26%), and relief of bladder pain with voiding (10%). Prior to being diagnosed with PVD, 71% were seen by 3-10 physicians; 89% were managed by a urologist. Of the 37% diagnosed with IC/BPS, 67% reported <20% improvement in bladder symptoms with various IC/BPS treatments: 74% followed behavioral modifications, 70% used pentosan polysulfate sodium or amitriptyline, and 59% underwent bladder instillations or hydrodistention. 52% of patients were diagnosed with hormonally associated PVD treated with cessation of hormonal contraceptives (if currently using), and topical estradiol/testosterone creams. Other PVD pathophysiologies included neuro-proliferative PVD (30%) treated with vulvar vestibulectomy, and pelvic floor hypertonicity (74%) treated in part with physical therapy. Successful treatments for PVD improved bladder symptoms by ! 80% in 56% of patients and by ! 40% in 93% of patients. 78% of patients felt misdiagnosed with IC/BPS. CONCLUSIONS: Women with IC/BPS may have underlying PVD as pathophysiology and not an intrinsic bladder pathology. Urologic training should include vestibular examination and cotton swab testing, along with education concerning PVD management options (hormone treatment, pelvic floor physical therapy, and vestibulectomy) to best manage women with IC/PBS symptoms.
Source of Funding: None

PD44-05 WRITING IN THE MARGINS OF SEXUAL FUNCTION QUESTIONNAIRES: A QUALITATIVE ANALYSIS FROM WOMEN WITH PELVIC FLOOR DISORDERS
Pooja Parameshwar*, Jenna Borok, Lauren Wood, A. Lenore Ackerman, Karyn Eilber, Jennifer Anger, Los Angeles, CA INTRODUCTION AND OBJECTIVES: Pelvic floor disorders (PFDs) are associated with sexual dysfunction related to impaired arousal, absent or diminished orgasm, and pain, as well as lowered rates of sexual activity. As a result, it is a challenge to assess sexual function in women who are not sexually active. Many decline to answer questions, or may write comments in the margins of forced-choice surveys. "Marginalia" can offer rich, novel sources of data that validated surveys fail to capture. We sought to more comprehensively capture women's experiences by analyzing how women with PFDs respond to sexual function questionnaires.
METHODS: Women with PFDs completed validated written sexual function questionnaires [Study of Sexual Attitudes and Behaviors survey (SSABS), Female Sexual Function Index (FSFI), and Sexual Function for Women with POP, Urinary Incontinence and/or Fecal Incontinence (PISQ-IR)]. Marginalia, or the additions, eliminations, and changes subjects made (by hand) to survey items, were collected. Data were coded and analyzed using grounded theory methodology (Charmaz, 2006) . RESULTS: Ninety-four women completed surveys, the majority of whom experienced FSD (mean FSFI scores were 26.4AE5.8 for women <60 and 18.1AE12.4 for women 60+; 26.55 or less indicates FSD). Fifty-one (54%) subjects left marginalia, grouped into 4 types: narrative (n¼20), clarification (n¼65), elimination (n¼86), and confusion (n¼6). Narrative comments were unsolicited feedback or personal details. Clarifications were explanations or changes to survey items. Eliminations were "not applicable" notations or deletions. Confusion marginalia included question marks. Qualitative analysis revealed several themes (See Table 1 ). Elimination marginalia were commonly made on survey items addressing sexual activity or satisfaction. Fifty-nine (62.8%) subjects left one or more questions blank.
CONCLUSIONS: Analysis of marginalia from sexual function questionnaires amongst women with PFDs revealed critical, previously undocumented information about patients' histories, concerns, thoughts, and factors affecting sexual function. Further in-depth qualitative investigations along with the development of more effective, robust, and specific evaluation tools are key future directions needed to better address patient needs. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e881
Source This study aimed to evaluate the influences of LUTS on sexual well-being in Japanese women, as little is known on this topic. METHODS: We investigated 514 women recruited between August 6 and August 17, 2007, from the outpatient departments (except the departments of pediatrics, psychiatry and ophthalmology) at our hospital, regardless of the reason for visiting. All participants were asked to answer a standardized self-reported questionnaire. Using the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and the overactive bladder symptom score (OABSS), we evaluated urinary symptoms, including stress urinary incontinence, urgency, day time frequency, and nocturia. To assess satisfaction with sexual function, we asked the question "If you were to spend the rest of your life with your sexual function the way it is today, how would you feel about this?", with answer choices of "very satisfied", "somewhat satisfied", "neither satisfied nor dissatisfied", "somewhat dissatisfied" and "very dissatisfied", from part of a questionnaire from the Global Study of Sexual Attitudes and Behaviors (GSSAB) study. The top two categories for each aspect were collapsed to identify positive answers as being very or somewhat satisfied with the level of sexual function. We analyzed relationships between dissatisfaction with sexual function and other variables, including age, stress urinary incontinence, urgency (¼ once a day), daytime frequency (!8 times/day), and nocturia (¼ once a night). The chi-square test and logistic regression models were used for statistical analyses. Values of P<0.05 were considered statistically significant.
RESULTS: A total of 360 individuals completed the questionnaire (response rate, 70.0%). The mean (AEstandard deviation) age of respondents was 48.3 AE 13.2 years. Prevalences of stress urinary incontinence, urgency, daytime frequency, and nocturia were 35.4%, 3.1%, 39.6%, and 55.0%, respectively. Overall, the prevalence of dissatisfaction with sexual function was 55.4%. In univariate analysis, age, urgency, and nocturia were associated with dissatisfaction with sexual function. In multivariate analysis, a significant correlation was found between dissatisfaction with sexual function and both age (odds ratio (OR), 1.05; p<0.001) and urgency (OR, 9.19; p¼0.047) .
CONCLUSIONS: Our study confirmed age and urgency as independent risk factors for dissatisfaction with sexual function. These results suggest that urgency can offer a predictor of sexual dysfunction among Japanese women. INTRODUCTION AND OBJECTIVES: 40% of women in the United States experience concern with regard to sexual function. Female sexual function (FSF) can be broken down into different categories based on the domain involved, including desire, arousal, orgasm, and pain. There are multiple causes for FSF including physical, hormonal, and psychological etiologies, and patients may have additional risk factors that contribute to the dysfunction experienced including depression, obesity, and hypertension. This is especially relevant in West Virginia, which ranks among the highest for several of these risk factors. The presence of sexual dysfunction in patients with interstitial cystitis (IC) is significant and well documented. Herein, we report the data on 362 subjects indexed by the presence or absence of IC and compare the degree of sexual dysfunction associated with the disease.
Source of
METHODS: Domain values were obtained by employing the Female Sexual Function Index (FSFI), developed by Rosen, et. al,. This 19-item questionnaire evaluates FSD in six domains. Data was analyzed on an item-for-item basis and by the six domains of sexual dysfunction for our patients and compared to two control groups. The first consisted of 131 healthy volunteers (Rosen, 2000) and the second consisted of 127 patients with Female Sexual Arousal Disorder (FSAD). Statistical significance was determined with one-way ANOVA testing (P<0.05).
RESULTS: The table below compares our data with two comparison groups across the 6 domains measured by the FSFI. WVU patients with IC scored the lowest in arousal, lubrication, and orgasm, and had the lowest scores in each category compared with all other groups (P < 0.001). WVU patients without IC scored the lowest in arousal and desire, and had worse scores than the control in all categories.
CONCLUSIONS: This study is the first exploration of the Urologic patients in West Virginia with regard to FSF, and it highlights a vastly significant amount of sexual dysfunction within this population. West Virginia in 2015 had the 47th worst health ranking in the United States, with especially high prevalence of smoking, obesity, physical inactivity, heart disease and diabetes. Understanding the physical and psychological causes of female sexual dysfunction as well as the category of sexual function affected is critical for properly treating patients for their specific need.
